Investor
Housed on a biochip, the startup's technology can deliver results from a single drop of blood within 15 minutes.
Also: Funding announcements for Think Research, Kinetic and Aura.
The company said its new investment will fuel commercialization of its Pivot program, which consists of an app, a connected carbon monoxide breathalyzer and other resources.
CEO Robbie Cape said the investment will be used to meet demand, build new capabilities and ensure high-quality care.
The collective entity offers its vertically-integrated service to patients in Northern California, and is eyeing platform partnerships elsewhere in the country.
The company plans to use the new money to help speed up its growth and development.
The startup's seed funding comes from Lux Capital, former Twitter heads and others.
London-based FundamentalVR plans to work with the Mayo Clinic to develop new simulations and validate its technology.
Over the quarter, MobiHealthNews tracked $3.3 billion in digital health deals.